| SI2902030T1 (en) | | Thienotriazolodiazepine compounds for treating neoplasia |
| HUE043569T2 (en) | | Compounds for the treatment of cancer |
| ZA201006367B (en) | | Oxadiazoanthracene compounds for the treatment of diabetes |
| ZA201200409B (en) | | Compounds for the reduction of b-amyloid production |
| PL2482849T3 (en) | | Combination immunotherapy for the treatment of cancer |
| EP2409634A4 (en) | | Endoscope for treatment |
| IL213761A0 (en) | | Novel ortho-aminoamides for the treatment of cancer |
| PT2498603T (en) | | Use of anti-bacterial agents for the treatment of epithelial-related conditions |
| EP2440216A4 (en) | | Use of a composition for the treatment of mucositis |
| GB0900599D0 (en) | | Treatment |
| IL210066A0 (en) | | Novel ortho-aminoanilides for the treatment of cancer |
| IL217139A0 (en) | | Process for the preparation of arylpyridinyl compounds |
| GB201012926D0 (en) | | Compounds for treatment of inflammation |
| GB0913968D0 (en) | | Treatment |
| GB0901411D0 (en) | | Treatment |
| PL2515897T3 (en) | | A combination for the treatment of osteoarthritis |
| GB0908699D0 (en) | | Compounds for the treatment of neoplasia |
| GB0920317D0 (en) | | Compounds for the treatment of neoplasia |
| GB0906202D0 (en) | | Compounds for the treatment of neoplasia |
| GB0914476D0 (en) | | Compounds for the treatment of neoplasia |
| GB0905895D0 (en) | | Process for the preparation of chalcogenone compounds |
| GB0906026D0 (en) | | Therapeutic compounds |
| GB0819536D0 (en) | | Compounds for the treatment of neoplasia |
| GB0817857D0 (en) | | Compounds for the treatment of neoplasia |
| GB201019110D0 (en) | | Compounds for the treatment of neoplasia |